Ehsan Sadri Md Facs

Founder and CEO at Visionary Eye Institute/International Speaker/VC/Serial Entrepreneur Advisor

๐Ÿ“ Newport Beach, California, United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 1 investments๐Ÿ“… 10 years investing๐Ÿ—“ Last invested Mar 2016๐• @upgrade_to_unlock
Operator-angel๐ŸŒ United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Founding Board Member
Mar 2016
Visionary is a venture capital firm that invests in the most promising emerging ophthalmology companies in medical devices and pharmaceuticals. With many breakthrough ophthalmic technologies and platforms on the horizon, Visionary Venture Fund was created to help these companies by contributing clinical expertise, commercialization know-how, and growth capital. We work hand-in-hand with todays most promising ophthalmic technologies to create tomorrows commercial blockbusters. Were looking for visionary entrepreneurs, proven teams, and strong IP to create exciting ideas that address large unmet needs in ophthalmology in order to create market-leading businesses. We are a focused venture capital fund from round A to commercialization. Our target investments range from $500K to $5M in financing rounds ranging from $5M to $15MM. We seek to be lead investors and a partner of choice in our deals as we bring a strong KOL doctor partnership to the table.
Experience ยท 4 entries
All (4)
Investments (1)
Founder (2)
Board (1)
2019
Visionary Eye Institute
Founder and CEO
Sep 2019
2016
Founding Board Member
Mar 2016
Visionary is a venture capital firm that invests in the most promising emerging ophthalmology companies in medical devices and pharmaceuticals. With many breakthrough ophthalmic technologies and platforms on the horizon, Visionary Venture Fund was created to help these companies by contributing clinical expertise, commercialization know-how, and growth capital. We work hand-in-hand with todays most promising ophthalmic technologies to create tomorrows commercial blockbusters. Were looking for visionary entrepreneurs, proven teams, and strong IP to create exciting ideas that address large unmet needs in ophthalmology in order to create market-leading businesses. We are a focused venture capital fund from round A to commercialization. Our target investments range from $500K to $5M in financing rounds ranging from $5M to $15MM. We seek to be lead investors and a partner of choice in our deals as we bring a strong KOL doctor partnership to the table.
2005
Atlantis Eye Care
Partner
Aug 2005
OC Glaucoma Society
Co-Founder and Past President
Aug 2005